Total Payments
$1,380
2024 Payments
$251.64
Companies
22
Transactions
73
Medicare Patients
957
Medicare Billing
$48,281
Payment Breakdown by Category
Food & Beverage$1,380 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,380 | 73 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $500.00 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $136.97 | 8 | $0 (2024) |
| Novo Nordisk Inc | $124.09 | 7 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $122.89 | 1 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.91 | 3 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $45.76 | 3 | $0 (2024) |
| Exact Sciences Corporation | $44.20 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $42.26 | 3 | $0 (2022) |
| Lilly USA, LLC | $39.56 | 3 | $0 (2021) |
| Abbott Laboratories | $38.20 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $251.64 | 13 | ABBVIE INC. ($120.49) |
| 2023 | $546.79 | 24 | ABBVIE INC. ($264.37) |
| 2022 | $282.29 | 16 | ABBVIE INC. ($101.55) |
| 2021 | $299.19 | 20 | Lilly USA, LLC ($39.56) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Inflammation | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Obesity | ||||||
| 08/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: VACCINE | ||||||
| 04/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: Oncology | ||||||
| 03/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: NEUROSCIENCE | ||||||
| 02/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: DIABETES | ||||||
| 02/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $31.83 | General |
| Category: NEUROSCIENCE | ||||||
| 01/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.91 | General |
| Category: RESPIRATORY | ||||||
| 01/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Obesity | ||||||
| 01/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/28/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $27.64 | General |
| Category: Oncology | ||||||
| 12/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: NEUROSCIENCE | ||||||
| 11/10/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.94 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Hematology | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: VACCINES | ||||||
| 08/22/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: NEUROSCIENCE | ||||||
| 08/17/2023 | Currax Pharmaceuticals LLC | CONTRAVE (Drug), NEXLETOL, NEXLIZET | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 225 | 310 | $49,100 | $10,969 |
| 2022 | 7 | 251 | 325 | $50,038 | $12,810 |
| 2021 | 7 | 253 | 347 | $41,744 | $14,328 |
| 2020 | 6 | 228 | 283 | $33,715 | $10,173 |
Total Patients
957
Total Services
1,265
Medicare Billing
$48,281
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 123 | $22,140 | $5,078 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 68 | 81 | $10,935 | $3,079 | 28.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 15 | 15 | $1,650 | $931.70 | 56.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 43 | 43 | $11,825 | $853.02 | 7.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $570.00 | $400.40 | 70.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 11 | 11 | $1,210 | $348.27 | 28.8% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2023 | 11 | 22 | $770.00 | $278.63 | 36.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 122 | $21,652 | $5,012 | 23.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 75 | 90 | $11,638 | $3,643 | 31.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,420 | $1,501 | 62.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 39 | 39 | $10,638 | $1,026 | 9.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 25 | 25 | $950.00 | $675.15 | 71.1% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 15 | 15 | $1,350 | $534.60 | 39.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 12 | 12 | $1,390 | $418.65 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 62 | 122 | $21,106 | $5,357 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 40 | 40 | $7,520 | $4,306 | 57.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 74 | $8,806 | $2,553 | 29.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 23 | $2,490 | $1,492 | 59.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 28 | 29 | $1,102 | $452.98 | 41.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 27 | 45 | $636.00 | $135.00 | 21.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 14 | 14 | $84.00 | $31.50 | 37.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 41 | 41 | $7,708 | $3,861 | 50.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 63 | 93 | $16,089 | $3,239 | 20.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 56 | $6,664 | $1,294 | 19.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 21 | 21 | $1,890 | $1,274 | 67.4% |
About Amanda Frazier, APRN
Amanda Frazier, APRN is a Nurse Practitioner healthcare provider based in Burlington, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/20/2015. The National Provider Identifier (NPI) number assigned to this provider is 1235523879.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Frazier, APRN has received a total of $1,380 in payments from pharmaceutical and medical device companies, with $251.64 received in 2024. These payments were reported across 73 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,380).
As a Medicare-enrolled provider, Frazier has provided services to 957 Medicare beneficiaries, totaling 1,265 services with total Medicare billing of $48,281. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Location Burlington, KY
- Active Since 03/20/2015
- Last Updated 07/13/2022
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1235523879
Products in Payments
- VRAYLAR (Drug) $410.89
- QUVIVIQ (Drug) $122.89
- TRELEGY ELLIPTA (Drug) $81.08
- Wegovy (Drug) $52.31
- UBRELVY (Drug) $46.40
- JARDIANCE (Drug) $45.76
- Cologuard Collection Kit (Device) $44.20
- QULIPTA (Drug) $42.71
- XIFAXAN (Drug) $42.26
- TRULICITY (Drug) $39.56
- FREESTYLE LIBRE 2 (Device) $38.20
- SHINGRIX (Biological) $37.52
- VYVANSE (Drug) $35.94
- Ozempic (Drug) $30.27
- ENTRESTO (Drug) $29.78
- Otezla (Drug) $18.70
- AREXVY (Drug) $18.37
- GARDASIL 9 (Biological) $17.99
- GVOKE HYPOPEN (Drug) $17.09
- ACCRUFER (Drug) $15.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Burlington
Victoria Garcia-Albea, Np, NP
Nurse Practitioner — Payments: $10,428
Nurse Practitioner $10,428
Barbara Brady, Np, NP
Nurse Practitioner — Payments: $6,480
Nurse Practitioner $6,480
Trevor Packer, Fnp-C, FNP-C
Nurse Practitioner — Payments: $3,419
Nurse Practitioner $3,419
Ms. Donna Carroll, Npc, NPC
Nurse Practitioner — Payments: $3,332
Nurse Practitioner $3,332
Christopher Berge, Np, NP
Nurse Practitioner — Payments: $2,717
Nurse Practitioner $2,717
Monica Dube, Np, NP
Nurse Practitioner — Payments: $2,406
Nurse Practitioner $2,406